These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39044604)

  • 21. Stage-specific activity of pentavalent antimony against Leishmania donovani axenic amastigotes.
    Ephros M; Bitnun A; Shaked P; Waldman E; Zilberstein D
    Antimicrob Agents Chemother; 1999 Feb; 43(2):278-82. PubMed ID: 9925518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological evaluation and structure activity relationship of 9-methyl-1-phenyl-9H-pyrido[3,4-b]indole derivatives as anti-leishmanial agents.
    Ashok P; Chander S; Smith TK; Prakash Singh R; Jha PN; Sankaranarayanan M
    Bioorg Chem; 2019 Mar; 84():98-105. PubMed ID: 30500524
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of allicin on promastigotes and intracellular amastigotes of Leishmania donovani and L. infantum.
    Jesús Corral-Caridad M; Moreno I; Toraño A; Domínguez M; Alunda JM
    Exp Parasitol; 2012 Dec; 132(4):475-82. PubMed ID: 22995646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro effects of purine and pyrimidine analogues on Leishmania donovani and Leishmania infantum promastigotes and intracellular amastigotes.
    Azzouz S; Lawton P
    Acta Parasitol; 2017 Sep; 62(3):582-588. PubMed ID: 28682767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Racemoside A, an anti-leishmanial, water-soluble, natural steroidal saponin, induces programmed cell death in Leishmania donovani.
    Dutta A; Ghoshal A; Mandal D; Mondal NB; Banerjee S; Sahu NP; Mandal C
    J Med Microbiol; 2007 Sep; 56(Pt 9):1196-1204. PubMed ID: 17761483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-parasite activity of nucleoside analogues: the metabolism of carbocyclic inosine in promastigotes of Leishmania tropica and Leishmania donovani and its activity against amastigotes of Leishmania donovani in vitro.
    Wataya Y; Satake H; Hiraoka O; Aji T; Morishige K; Kimura JY; Ishii A; Matsuda A; Ueda T; Fukukawa K
    Nucleic Acids Symp Ser; 1986; (17):149-51. PubMed ID: 3562260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural products derived steroids as potential anti-leishmanial agents; disease prevalence, underlying mechanisms and future perspectives.
    Elawad MA; Elkhalifa MEM; Hamdoon AAE; Salim LHM; Ahmad Z; Ayaz M
    Steroids; 2023 May; 193():109196. PubMed ID: 36764565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani.
    Shaked-Mishan P; Ulrich N; Ephros M; Zilberstein D
    J Biol Chem; 2001 Feb; 276(6):3971-6. PubMed ID: 11110784
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania donovani develops resistance to drug combinations.
    García-Hernández R; Manzano JI; Castanys S; Gamarro F
    PLoS Negl Trop Dis; 2012; 6(12):e1974. PubMed ID: 23285310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of ureastibamine on Leishmania donovani amastigote.
    Ghosh AK; Mukerji K; Ghosh DK
    Indian J Med Res; 1990 May; 91():208-13. PubMed ID: 2397943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activity of a novel sulfonamide compound 2-nitro-N-(pyridin-2-ylmethyl)benzenesulfonamide against Leishmania donovani.
    Dikhit MR; Purkait B; Singh R; Sahoo BR; Kumar A; Kar RK; Ansari MY; Saini S; Abhishek K; Sahoo GC; Das S; Das P
    Drug Des Devel Ther; 2016; 10():1753-61. PubMed ID: 27307706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-β-carbolines.
    Manda S; Khan SI; Jain SK; Mohammed S; Tekwani BL; Khan IA; Vishwakarma RA; Bharate SB
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3247-50. PubMed ID: 24980054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Leishmanial and Cytotoxic Activities of a Series of Maleimides: Synthesis, Biological Evaluation and Structure-Activity Relationship.
    Fan Y; Lu Y; Chen X; Tekwani B; Li XC; Shen Y
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30400596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity of anti-leishmanial drugs against Leishmania donovani is host cell dependent.
    Seifert K; Escobar P; Croft SL
    J Antimicrob Chemother; 2010 Mar; 65(3):508-11. PubMed ID: 20089542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds.
    Ravinder ; Bhaskar ; Gangwar S; Goyal N
    Curr Microbiol; 2012 Dec; 65(6):696-700. PubMed ID: 22945482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidating the possible mechanism of action of some pathogen box compounds against Leishmania donovani.
    Amlabu WE; Antwi CA; Awandare G; Gwira TM
    PLoS Negl Trop Dis; 2020 Apr; 14(4):e0008188. PubMed ID: 32275665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mechanisms of in vitro betulin-induced apoptosis of Leishmania donovani.
    Saudagar P; Dubey VK
    Am J Trop Med Hyg; 2014 Feb; 90(2):354-60. PubMed ID: 24420777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peganum harmala and Nigella sativa: anti-leishmanial activity against Leishmania major promastigotes and amastigotes: in vitro and ex vivo experiment.
    Rokni N; Faridnia R; Esboei BR; Eslami S; Fakhar M; Youssefi MR; Kalani H; Keighobadi M
    Ann Parasitol; 2021; 67(2):313-319. PubMed ID: 34598403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid fluorescent assay for screening drugs on Leishmania amastigotes.
    Shimony O; Jaffe CL
    J Microbiol Methods; 2008 Oct; 75(2):196-200. PubMed ID: 18573286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
    Kumar V; Kumari S; Ranjan R; Kumar A; Alti D
    Exp Parasitol; 2024 Feb; 257():108688. PubMed ID: 38142765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.